Clinical Trials Directory

Trials / Completed

CompletedNCT04722549

Effects of Butyrate on Affective Processes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The effects of butyrate on psychobiological processes are examined in a sample of healthy volunteers.

Detailed description

The study is an interventional triple-blind, placebo-controlled, parallel group design with 2 arms (placebo, butyrate). Healthy male participants adhere to a low-fiber diet for the duration of the study (11 days). At the baseline study visit, measurements are taken in the lab, including biological samples and psychophysiological measurements. Participants then consume placebo or butyrate for 1 week and revisit the lab on day 11 for a second measurement of the outcomes of interest. Specifically, we investigate the effect of colonic butyrate administration on affective processing, including stress sensitivity and fear-related processes (e.g. extinction learning). Volunteers also respond to questionnaires in relation to mood and GI symptoms, and provide biological samples (saliva, blood, and faecal samples) for analysis of cortisol levels, circulating short chain fatty acids and serum BDNF, and faecal SCFA, respectively.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboCellulose
DIETARY_SUPPLEMENTButyrateSodium butyrate

Timeline

Start date
2021-02-08
Primary completion
2022-12-11
Completion
2022-12-11
First posted
2021-01-25
Last updated
2023-01-04

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04722549. Inclusion in this directory is not an endorsement.